Concussions Market Segmentation by Diagnosis (Magnetic Resonance Imaging Devices, Computed Tomography Scan, X-ray, and Others); by Treatment (Over-the-counter Pain Relievers, Brain Tests, and Others); and by End-User (Hospitals and Clinics, Diagnostic Centres, Medical Camps, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Report ID : 10085597 |
Published Date : 21 Mar 2025 |
Report Format : PDF,PPT |
Delivery Timeline :48-72 Business Hours
Global Concussions Market Highlights Over 2022 – 2031
The global concussions market is estimated to garner modest revenue of approximately USD 9270 million by growing at a CAGR of ~4% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to an increasing number of injuries from sports, road accidents, the aging population, and others. A concussion is a mild traumatic brain injury temporarily disrupting the brain's normal function. Factors contributing to the growth of global concussions market are the growth of research activities on the treatment and diagnosis of concussion and increase in the use of technologically advanced products. According to the World Bank, the aging population all over the world was, in 2020, 700 million which significantly rose to 723 million in 2021 and it is likely to increase noticeably in the forecast period.
The global concussions market is segmented on the basis of end-user into hospitals & clinics, diagnostic centers, medical camps, and others. Out of these, the hospital & clinics segment is expected to grow significantly during the forecast period, on the back of increasing incidence of mild traumatic brain injuries and a growing number of geriatric populations worldwide.
GET A SAMPLE COPY OF THIS REPORT
Global Concussions Market Regional Synopsis
Regionally, the global concussions market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North America region held the largest market share in 2021 and is anticipated to continue to lead the market during the forecast period, owing to the increasing number of concussion cases resulting from brain injuries, and increasing awareness by government organizations and other private firms. Moreover, the greater incidence rate of concussions due to road accidents and sports injuries will lead to increasing support from state and federal governments through awareness campaigns regarding concussion prevention, diagnosis, and treatment are some of such key drivers. According to the Centres for Disease Control and Prevention (CDC), approximately 223,135 patients were treated in the United States for concussion-related cases in 2019.
Market Segmentation
Our in-depth analysis of the global concussions market includes the following segments:
By Diagnosis
-
Magnetic Resonance Imaging Devices
-
Computed Tomography Scan
-
X-ray
-
Others
By Treatment
-
Over-the-counter Pain Relievers
-
Brain Tests
-
Others
By End-User
-
Hospitals and Clinics
-
Diagnostic Centres
-
Medical Camps
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Concussions Market
Growth Drivers:
-
Rising Road Accidents and Sports Injuries
-
Technological Advancements in Healthcare Sector
Challenges:
-
Lack of Awareness Associated with Concussion Treatment
Key Companies Dominating the Global Concussions Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global concussions market that are included in our report are Compumedics Ltd., Integra LifeSciences Corporation, InfraScan, Inc, Raumedic AG, Teva Pharmaceutical Industries Ltd., Medtronic PLC, Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals Ltd., Zydus Group, and others.
Latest Developments in the Global Concussions Market:
-
18 May, 2022 - Raumedic AG to undergo significant rebranding process, in order to modernize the image of the company.
-
25 June, 2021 - The USFDA has given Zydus Cadila provisional clearance to market the Pemetrexed drug injection in single-dose vials with strengths of 100 mg, 500 mg, and 1000 mg.
Key Reasons to Buy Our Report
-
The report covers a detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Frequently Asked Question
The market is segmented by diagnostic & treatment and end-user.
The hospitals and clinics segment under end-user segment is anticipated to hold largest market size over the forecast period and display significant growth opportunities.
More Reports from Healthcare & Pharmaceuticals Sector
Thank you for contacting us!
""We have received your sample request for the research report. Our research representative will contact you shortly.""